Glucotrack, Inc. Debt Conversion, Converted Instrument, Amount
Glucotrack, Inc. (GCTK) reported Debt Conversion, Converted Instrument, Amount of $2.28 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-03-30
- Glucotrack, Inc. debt conversion, converted instrument, amount for fiscal 2024 was $2.28M.
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2024-12-31 | $2.28M 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |